Kathleen Syeb
Papers
1
Total Citations
3
H-Index
1
About
Kathleen Syeb is a researcher whose work has centered on the development of innovative screening methodologies for neurodegenerative disease therapeutics. Her primary research focus lies in the design of high-throughput assays to identify inhibitors of key pathological processes, particularly those involving protein misfolding and aggregation—hallmark features of disorders such as Alzheimer’s and Parkinson’s disease. Syeb’s most notable contribution is the creation of a fluorescent quenching-based high-throughput assay to screen for calcineurin inhibitors, a method that addresses the urgent need for effective treatments where none currently exist. This work, published in 2015, has garnered 3 citations and represents a foundational step toward accelerating drug discovery in a field hampered by the complexity of protein aggregation pathways. By enabling rapid, scalable screening of potential therapeutic compounds, Syeb’s assay provides a critical tool for researchers aiming to halt or reverse the progression of devastating neurodegenerative conditions. Her efforts underscore a commitment to bridging the gap between basic molecular mechanisms and practical, high-efficiency screening platforms, offering hope for future interventions in diseases that currently lack disease-modifying therapies.
Research Focus
Key Achievements
Top Papers
- 1